While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

Medtronic expects Trump administration tariffs and reciprocal tariffs from other countries to cost it $200–350 million over ...

The medical device maker has been working to turn around the division over the past few years.

Medtronic (NYSE: MDT) announced some personnel moves, including the departure of a longtime leader across multiple business ...

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.

Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

Medical device maker Medtronic plans to separate its diabetes business into a stand-alone company, the Wall Street Journal ...